Ineffective control of Epstein-Barr virus infection is seen in MS: What is next?
作者信息
Rommer Paulus, Puchhammer-Stöckl Elisabeth, Lassmann Hans, Berger Thomas, Vietzen Hannes
机构信息
Department of Neurology, Medical University of Vienna, Vienna, Austria.
Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
出版信息
Clin Transl Med. 2024 Feb;14(2):e1596. doi: 10.1002/ctm2.1596.
Abstract
摘要
相似文献
1
Ineffective control of Epstein-Barr virus infection is seen in MS: What is next?
Clin Transl Med. 2024 Feb;14(2):e1596. doi: 10.1002/ctm2.1596.
2
Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
Clin Infect Dis. 2008 Jan 15;46(2):313-6. doi: 10.1086/524079.
3
Serum Epstein-Barr virus (EBV) viral load can be a complementary sensitive test in primary Epstein-Barr virus infection.
J Clin Virol. 2011 Feb;50(2):184-5. doi: 10.1016/j.jcv.2010.11.002. Epub 2010 Nov 26.
4
How does Epstein-Barr virus trigger MS?
Immunity. 2022 Mar 8;55(3):390-392. doi: 10.1016/j.immuni.2022.02.008.
5
Case Report: Epstein-Barr Virus Encephalitis Complicated With Brain Stem Hemorrhage in an Immune-Competent Adult.
Front Immunol. 2021 Feb 25;12:618830. doi: 10.3389/fimmu.2021.618830. eCollection 2021.
6
The immune response to Epstein-Barr virus.
Microbes Infect. 2004 Aug;6(10):937-45. doi: 10.1016/j.micinf.2004.04.014.
7
Epstein - Barr virus Pneumonitis.
Ulster Med J. 2009 May;78(2):137-8.
8
Primary Epstein-Barr virus hepatitis complicated by ascites with epstein-barr virus reactivation during primary cytomegalovirus infection.
J Pediatr Gastroenterol Nutr. 2003 Jul;37(1):87-90. doi: 10.1097/00005176-200307000-00016.
9
[Updates on Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated tumors].
Zhonghua Bing Li Xue Za Zhi. 2014 Aug;43(8):571-4.
10
Epstein-Barr virus and human herpesvirus type 6 infection in patients with psoriasis.
Eur J Dermatol. 2006 Sep-Oct;16(5):548-52.
本文引用的文献
1
Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations.
Nature. 2024 Jan;625(7994):321-328. doi: 10.1038/s41586-023-06618-z. Epub 2024 Jan 10.
2
Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis.
Cell. 2023 Dec 21;186(26):5705-5718.e13. doi: 10.1016/j.cell.2023.11.015. Epub 2023 Dec 12.
3
Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis.
EBioMedicine. 2023 Oct;96:104789. doi: 10.1016/j.ebiom.2023.104789. Epub 2023 Sep 11.
4
Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis.
Sci Adv. 2023 May 19;9(20):eadg3032. doi: 10.1126/sciadv.adg3032. Epub 2023 May 17.
5
Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy.
Lancet Neurol. 2023 Apr;22(4):338-349. doi: 10.1016/S1474-4422(22)00471-9. Epub 2023 Feb 7.
6
Infectious mononucleosis is associated with an increased incidence of multiple sclerosis: Results from a cohort study of 32,116 outpatients in Germany.
Front Immunol. 2022 Aug 2;13:937583. doi: 10.3389/fimmu.2022.937583. eCollection 2022.
7
A plausible contributor to multiple sclerosis; presentation of antigenic myelin protein epitopes by major histocompatibility complexes.
Comput Biol Med. 2022 Sep;148:105856. doi: 10.1016/j.compbiomed.2022.105856. Epub 2022 Jul 14.
8
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM.
Nature. 2022 Mar;603(7900):321-327. doi: 10.1038/s41586-022-04432-7. Epub 2022 Jan 24.
9
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.
Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13.
10
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
JCI Insight. 2020 Oct 15;5(20):144624. doi: 10.1172/jci.insight.144624.
Zotero 插件